We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

64 hedge funds and large institutions have $948M invested in Stoke Therapeutics in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 4

180% more capital invested

Capital invested by funds: $339M → $948M (+$609M)

145% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 11

53.6% more ownership

Funds ownership: 48.7% → 102.3% (+54%)

21% more funds holding

Funds holding: 53 → 64 (+11)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
64
Holders Change
+11
Holders Change %
+20.75%
% of All Funds
1.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
27
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.56M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$4.97M
3
RI
RTW Investments
New York
+$4.75M
4
Victory Capital Management
Victory Capital Management
Texas
+$4.42M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.8M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$9.44M
2
OAM
Oxford Asset Management
United Kingdom
-$2.5M
3
SFM
Sphera Funds Management
Israel
-$2.26M
4
GGHC
Gilder Gagnon Howe & Co
New York
-$1.24M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$647K
Name Holding Trade Value Shares
Change 		Change in
Stake
ZP
26
Zimmer Partners
New York
$708K – – –
N
27
Nuveen
North Carolina
$606K -$50K -1,987 -8%
Squarepoint
28
Squarepoint
New York
$574K -$35.5K -1,413 -7%
TD Asset Management
29
TD Asset Management
Ontario, Canada
$563K – – –
Wells Fargo
30
Wells Fargo
California
$510K +$367K +14,589 +424%
Morgan Stanley
31
Morgan Stanley
New York
$496K +$288K +11,459 +190%
Swiss National Bank
32
Swiss National Bank
Switzerland
$442K +$392K +15,600 New
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$410K +$364K +14,470 New
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$404K – – –
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$394K – – –
GPCM
36
Granite Point Capital Management
Massachusetts
$374K -$95.6K -3,800 -22%
Citadel Advisors
37
Citadel Advisors
Florida
$296K +$263K +10,465 New
Barclays
38
Barclays
United Kingdom
$278K +$96.5K +3,835 +64%
AC
39
Athanor Capital
New York
$273K -$114K -4,543 -32%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$272K – – –
UBS Group
41
UBS Group
Switzerland
$259K +$77.3K +3,075 +51%
Ensign Peak Advisors
42
Ensign Peak Advisors
Utah
$256K +$228K +9,073 New
ProShare Advisors
43
ProShare Advisors
Maryland
$236K +$209K +8,317 New
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$225K +$200K +7,939 New
FAM
45
Fred Alger Management
New York
$170K -$151K -6,000 -50%
AIG
46
American International Group
New York
$162K -$1.21K -48 -0.8%
MIM
47
MetLife Investment Management
New Jersey
$135K +$120K +4,762 New
Citigroup
48
Citigroup
New York
$124K +$100K +3,985 +979%
SG Americas Securities
49
SG Americas Securities
New York
$116K +$103K +4,092 New
Bank of America
50
Bank of America
North Carolina
$102K -$2.54K -101 -3%
1
2
3

STOK Hedge Fund Activity: Q4 2019 in Review

64 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q4 2019, worth a combined $948M — up 180% from $339M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new STOK positions and 4 closed out — a net gain of 11 holders — while 27 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $7.56M. The largest seller was Millennium Management, cutting an estimated $9.44M.

  • 64 institutional investors held Stoke Therapeutics (STOK) as of Q4 2019, up from 53 in Q3 2019.
  • Funds reported $948M of Stoke Therapeutics stock for Q4 2019, up 180% quarter-over-quarter.
  • 15 funds opened new Stoke Therapeutics positions in Q4 2019 and 4 closed out, a net change of +11 holders.
  • The largest Stoke Therapeutics buyer in Q4 2019 was BlackRock, an estimated $7.56M added.
  • The largest Stoke Therapeutics seller in Q4 2019 was Millennium Management, an estimated $9.44M sold.

Based on aggregated 13F filings for Q4 2019.